Table 2 Clinical presentation, findings and investigations, N = 808
Variable | n (%) | n (%) |
|---|---|---|
Presenting VA in better eye | ||
6/5 to 6/12 | 271(67.1) | |
> 6/12 to 6/18 | 49 (12.1) | |
> 6/18 to 6/60 | 59 (14.6) | |
> 6/60 to 3/60 | 14 (3.5) | |
> 3/60 | 11 (2.7) | |
Presenting VA in worse eye | ||
6/5 to 6/12 | 203 (50.2) | |
> 6/12 to 6/18 | 63 (15.6) | |
> 6/18 to 6/60 | 56 (13.9) | |
> 6/60 to 3/60 | 45(11.1) | |
> 3/60 | 37 (9.2) | |
Examination findings | RE | LE |
Conjunctival hyperemia | 100 (24.8) | 92 (22.8) |
Pterygium | 51 (12.7) | 45 (11.2) |
Arcus senilis | 189 (39.5) | 189 (39.5) |
Cells in A/C | 12 (3.0) | 13 (3.2) |
Pseudoexfoliation | 89 (22.1) | 80 (19.8) |
Lens opacification | 188 (46.5) | 175 (43.3) |
Vitreous degeneration | 19 (4.9) | 15 (3.9) |
Retinal hemorrhage | 07 (1.7) | 07 (1.7) |
Retinal detachment | 06 (1.5) | 05 (1.2) |
Retinal exudates | 01 (0.3) | 02 (0.5) |
Mean IOP(SD)* | 15.0 (6.0) | 14.8 (5.8) |
Mean Corneal diameter (SD)* | 10.9 (0.6) | 10.9 (0.6) |
Tear film instability | 48 (12.1) | 44 (11.1) |
Diagnostic parameters | ||
Mean CCT (SD)* | 522.9 (39.0) | 524.8 (37.7) |
Mean Keratometry (SD)* | 43.9 (2.4) | 43.7 (2.1) |
Mean AXL (SD)* | 22.8 (1.1) | 22.7 (0.9) |
Mean ACD (SD)* | 2.9 (0.4) | 2.9 (0.4) |